[Retrospective study of fertility in female patients with hematological diseases after allogeneic hematopoietic stem cell transplantation] [0.03%]
造血干细胞移植女患者移植后生育能力的回顾性研究
J Y Huang,W S X Huang,B X Jiang et al.
J Y Huang et al.
Objective: This study aimed to investigate the impact of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on fertility in female patients with hematological diseases as well as the feasibility of fertility preservation and con...
[Clinical application value of detecting the mutation load of the FLT3-ITD gene before allogeneic hematopoietic stem cell transplantation using PCR-NGS technology] [0.03%]
基于PCR-NGS技术检测供者FLT3-ITD基因突变负荷的临床应用价值研究
Y C Shao,Y X Zhang,W L Sun et al.
Y C Shao et al.
Objective: This study aimed to develop a methodology for detecting FMS-like tyrosine kinase 3 (FLT3) gene internal tandem duplication (ITD) mutation burden using polymerase chain reaction-next-generation sequencing (PCR-NGS). The prognostic...
[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population] [0.03%]
马立巴韦治疗接受器官移植受者巨细胞病毒感染有效性和安全性与缬更昔洛韦比较的Ⅲ期、多中心、随机、双盲、阳性对照试验（AURORA研究）的中国亚组分析
L Xuan,H Huang,L P Xu et al.
L Xuan et al.
Objective: This study aimed to compare the efficacy and safety of maribavir and valganciclovir in the treatment of asymptomatic cytomegalovirus (CMV) infection in hematopoietic stem cell transplant (HSCT) recipients. Methods: In this phase ...
[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management] [0.03%]
CAR-T细胞治疗B细胞急性淋巴细胞白血病复发/难治病例全程管理要点体会
Y Wang
Y Wang
Remission rate of newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) based on chemotherapy was high; however, recurrence and refractory diseases still affect long-term survival, especially in adult patients. Chimeric antigen recept...
[Chinese guideline on the diagnosis and treatment of adult primary immune thrombocytopenia (2025)] [0.03%]
中国成人原发性免疫性血小板减少症诊断与治疗指南（2025）
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association
Thrombosis and Hemostasis Group
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by impaired immune tolerance, leading to increased platelet destruction and decreased platelet production. In recent years, with population structure chan...
[Chinese expert consensus on the diagnosis and management of nodal peripheral T-cell lymphoma (2025)] [0.03%]
中国周边T细胞淋巴瘤(T-NK)诊疗专家共识(2025)
Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO);Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association
Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO);Lymphoid Disease Group
Peripheral T-cell lymphomas (PTCL) are a common type of non-Hodgkin lymphoma in China, with a higher incidence compared to Western countries. Apart from extranodal NK/T-cell lymphoma, nodal PTCL is the most prevalent subtype in China. Nodal...
[Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)] [0.03%]
中国慢性髓性白血病诊断与治疗指南（2025年版）
Chinese Society of Hematology, Chinese Medical Association
Chinese Society of Hematology
The guideline for the diagnosis and treatment of chronic myeloid leukemia (CML) in China (2025 edition) has been revised based on its 2020 version, incorporating advances in the field of CML diagnosis and treatment over the past 5 years. Wi...
[Value of gene mutation in the prognosis and treatment of multiple myeloma] [0.03%]
基因突变在多发性骨髓瘤预后及治疗中的价值分析
L L Cheng,J L Zhuang
L L Cheng
Multiple myeloma (MM) is a highly het1076erogeneous hematologic malignancy driven by complex genetic and molecular abnormalities. Driver gene mutations, particularly in the RAS/MAPK, DNA damage repair, and NF-κB pathways, are central to MM...
[Donor leukemia relapse and conversion type after allogeneic hematopoietic stem cell transplantation: a case report] [0.03%]
[异基因造血干细胞移植后供者型白血病复发及转化1例报告]
R J Li,M Xiong,G Wang et al.
R J Li et al.
[Primary familial and congenital polycythemia caused by EPOR gene mutation: two cases report and literature review] [0.03%]
原EPOR基因突变引起的原发性家族性和先天性红细胞增多症两例报告及文献复习
D H Ning,M Jiao,L Qin et al.
D H Ning et al.
In this paper, two cases of primary familial and congenital polycythemia (PFCP) were reported, and the literature was reviewed. PFCP is a rare autosomal dominant inherited disease caused by a gain-of-function mutation in the EPOR gene, resu...